The use of BMSCs-Exos has been found to have a significant role in meliorating DKD, through inhibiting excessive infiltration of immune cells and mitigating the generation of proinflammatory factors by downregulating the ICAM-1 expression [64]. The gene discussed is ICAM1; the disease is diabetic kidney disease.